UTOMILUMAB
UNII 6YY8O697VF

Substance Identification & Data

This profile provides standardized clinical and technical data for Utomilumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6YY8O697VF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1417318-27-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6YY8O697VF

CAS Registry Number

1417318-27-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

UTOMILUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C116619

National Cancer Institute reference terminology for clinical and research data.

INN ID

10385

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-163

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Utomilumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

UTOMILUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2, ANTI-(HUMAN RECEPTOR 4-1BB) (HUMAN MONOCLONAL PF-05082566 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-05082566 LIGHT CHAIN, DIMER

UTOMILUMAB [INN]

UTOMILUMAB [USAN]

UTOMILUMAB [WHO-DD]